共 50 条
[26]
Cost-effectiveness analysis of the Optifast 52 program in patients with grade III obesity and type 2 diabetes mellitus
[J].
AKTUELLE ERNAHRUNGSMEDIZIN,
2022, 47 (06)
:444-452
[27]
Cost-Effectiveness Analysis of the Optifast 52 Program in Patients with Grade III Obesity and Type 2 Diabetes mellitus
[J].
GESUNDHEITSOEKONOMIE UND QUALITAETSMANAGEMENT,
2022, 27 (04)
:192-200